$3.87
0.24 (+6.61%)
GTx, Inc. (GTXI)
CAPS Rating:
A biopharmaceutical company dedicated to the discovery, development & commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis & bone loss, muscle wasting & other serious medical conditions.

RSS Headlines
Fool UK